{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:12:43Z","timestamp":1779973963530,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40121-026-01356-x","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:30:14Z","timestamp":1778153414000},"page":"1779-1799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus Detection in Children and Adults: A Systematic Literature Review"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-8314","authenticated-orcid":false,"given":"Kashmira","family":"Date","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Lynn","family":"Baniecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine K.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima S.","family":"Toussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Seabroke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Chatzikonstantinidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Sarabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"11","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191\u2013210.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s40121-023-00802-4","volume":"12","author":"MH Rozenbaum","year":"2023","unstructured":"Rozenbaum MH, Begier E, Kurosky SK, et al. Incidence of respiratory syncytial virus infection in older adults: limitations of current data. Infect Dis Ther. 2023;12(6):1487\u2013504.","journal-title":"Infect Dis Ther"},{"issue":"2","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40121-023-00758-5","volume":"12","author":"MH Rozenbaum","year":"2023","unstructured":"Rozenbaum MH, Judy J, Tran D, Yacisin K, Kurosky SK, Begier E. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States. Infect Dis Ther. 2023;12(2):677\u201385.","journal-title":"Infect Dis Ther"},{"issue":"11","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14737159.2024.2408745","volume":"24","author":"A Domnich","year":"2024","unstructured":"Domnich A, Massaro E, Icardi G, Orsi A. Multiplex molecular assays for the laboratory-based and point-of-care diagnosis of infections caused by seasonal influenza, COVID-19, and RSV. Expert Rev Mol Diagn. 2024;24(11):997\u20131008.","journal-title":"Expert Rev Mol Diagn"},{"key":"1356_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad185","author":"C Onwuchekwa","year":"2023","unstructured":"Onwuchekwa C, Atwell J, Moreo LM, et al. Pediatric respiratory syncytial virus diagnostic testing performance: a systematic review and meta-analysis. J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/infdis\/jiad185.","journal-title":"J Infect Dis"},{"key":"1356_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318157da6f","author":"KJ Henrickson","year":"2007","unstructured":"Henrickson KJ, Hall CB. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J. 2007. https:\/\/doi.org\/10.1097\/INF.0b013e318157da6f.","journal-title":"Pediatr Infect Dis J"},{"key":"1356_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad012","author":"C Onwuchekwa","year":"2023","unstructured":"Onwuchekwa C, Moreo LM, Menon S, et al. Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/infdis\/jiad012.","journal-title":"J Infect Dis"},{"key":"1356_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01816-15","author":"C Chartrand","year":"2015","unstructured":"Chartrand C, Tremblay N, Renaud C, Papenburg J. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol. 2015. https:\/\/doi.org\/10.1128\/JCM.01816-15.","journal-title":"J Clin Microbiol"},{"key":"1356_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00805-1","author":"J Ramirez","year":"2023","unstructured":"Ramirez J, Carrico R, Wilde A, et al. Diagnosis of respiratory syncytial virus in adults substantially increases when adding sputum, saliva, and serology testing to nasopharyngeal swab RT\u2013PCR. Infect Dis Ther. 2023. https:\/\/doi.org\/10.1007\/s40121-023-00805-1.","journal-title":"Infect Dis Ther"},{"key":"1356_CR10","unstructured":"Larkins MC, Zubair M, Thombare A. Point-of-care testing. Treasure Island (FL): StatPearls; 2023."},{"issue":"2","key":"1356_CR11","first-page":"140","volume":"32","author":"JH Nichols","year":"2021","unstructured":"Nichols JH. Utilizing point-of-care testing to optimize patient care. EJIFCC. 2021;32(2):140\u20134.","journal-title":"EJIFCC"},{"key":"1356_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2855-1","author":"SV Schnee","year":"2017","unstructured":"Schnee SV, Pfeil J, Ihling CM, Tabatabai J, Schnitzler P. Performance of the Alere\u00a0i RSV assay for point-of-care detection of respiratory syncytial virus in children. BMC Infect Dis. 2017. https:\/\/doi.org\/10.1186\/s12879-017-2855-1.","journal-title":"BMC Infect Dis"},{"key":"1356_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00367-18","author":"MM Azar","year":"2018","unstructured":"Azar MM, Landry ML. Detection of influenza A and B viruses and respiratory syncytial virus by use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-waived point-of-care assays: a paradigm shift to molecular tests. J Clin Microbiol. 2018. https:\/\/doi.org\/10.1128\/JCM.00367-18.","journal-title":"J Clin Microbiol"},{"key":"1356_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11143942","author":"E Farfour","year":"2022","unstructured":"Farfour E, Yung T, Baudoin R, Vasse M. Evaluation of four fully integrated molecular assays for the detection of respiratory viruses during the co-circulation of SARS-CoV-2, influenza and RSV. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11143942.","journal-title":"J Clin Med"},{"key":"1356_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00084-16","author":"MG Wahrenbrock","year":"2016","unstructured":"Wahrenbrock MG, Matushek S, Boonlayangoor S, Tesic V, Beavis KG, Charnot-Katsikas A. Comparison of cepheid Xpert Flu\/RSV XC and BioFire FilmArray for detection of influenza A, influenza B, and respiratory syncytial virus. J Clin Microbiol. 2016. https:\/\/doi.org\/10.1128\/jcm.00084-16.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1356_CR16","first-page":"e00228","volume":"34","author":"SHS Tali","year":"2021","unstructured":"Tali SHS, LeBlanc JJ, Sadiq Z, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 detection. Clin Microbiol Rev. 2021;34(3):e00228-e320.","journal-title":"Clin Microbiol Rev"},{"issue":"16","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","volume":"388","author":"EE Walsh","year":"2023","unstructured":"Walsh EE, Gonzalo PM, Zareba AM, et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N Engl J Med Overseas Ed. 2023;388(16):1465\u201377.","journal-title":"N Engl J Med Overseas Ed"},{"issue":"1","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"2209000","DOI":"10.1080\/21645515.2023.2209000","volume":"19","author":"C Weil-Olivier","year":"2023","unstructured":"Weil-Olivier C, Salisbury D, Navarro-Alonso JA, et al. Immunization technologies: time to consider new preventative solutions for respiratory syncytial virus infections. Hum Vaccin Immunother. 2023;19(1):2209000.","journal-title":"Hum Vaccin Immunother"},{"key":"1356_CR19","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.gpeds.2023.100130","volume":"7","author":"AC Vittucci","year":"2024","unstructured":"Vittucci AC, Antilici L, Dotta A, Cutrera R, Villani A. Respiratory syncytial virus infection: new prevention strategies. Glob Pediatr. 2024;7:100130.","journal-title":"Glob Pediatr"},{"key":"1356_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30703-9","author":"Y Li","year":"2021","unstructured":"Li Y, Hodgson D, Wang X, Atkins KE, Feikin DR, Nair H. Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study. Lancet Infect Dis. 2021. https:\/\/doi.org\/10.1016\/S1473-3099(20)30703-9.","journal-title":"Lancet Infect Dis"},{"key":"1356_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00291-2","author":"NI Mazur","year":"2023","unstructured":"Mazur NI, Terstappen J, Baral R, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2023. https:\/\/doi.org\/10.1016\/S1473-3099(22)00291-2.","journal-title":"Lancet Infect Dis"},{"key":"1356_CR22","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7229a4","author":"M Melgar","year":"2023","unstructured":"Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023. MMWR Morb Mortal Wkly Rep. 2023. https:\/\/doi.org\/10.15585\/mmwr.mm7229a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1356_CR23","unstructured":"European Medicines Agency. Abrysvo: respiratory syncytial virus vaccine (bivalent, recombinant). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abrysvo. Accessed 2025 May\u00a019."},{"key":"1356_CR24","unstructured":"US Food and Drug Administration. ABRYSVO. https:\/\/www.fda.gov\/vaccines-blood-biologics\/abrysvo. Accessed 2025 May\u00a019."},{"key":"1356_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-01844-9","author":"S Manti","year":"2025","unstructured":"Manti S, Baraldi E. Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection. Ital J Pediatr. 2025. https:\/\/doi.org\/10.1186\/s13052-025-01844-9.","journal-title":"Ital J Pediatr"},{"key":"1356_CR26","unstructured":"Enanta Pharmaceuticals, Inc. A study of EDP-938 in non-hospitalized adults with RSV who are at high risk for complications. https:\/\/clinicaltrials.gov\/study\/NCT05568706."},{"key":"1356_CR27","unstructured":"Enanta Pharmaceuticals, Inc. A study to evaluate EDP 938 regimens in children with RSV (RSVPEDs). https:\/\/clinicaltrials.gov\/study\/NCT04816721. Accessed  2025 May 19."},{"issue":"12","key":"1356_CR28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2313551","volume":"391","author":"S Zhao","year":"2024","unstructured":"Zhao S, Shang Y, Yin Y, et al. Ziresovir in hospitalized infants with respiratory syncytial virus infection. N Engl J Med. 2024;391(12):1096\u2013107.","journal-title":"N Engl J Med"},{"key":"1356_CR29","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1356_CR30","unstructured":"National Institute for Health Research. PROSPERO. International prospective register of systematic reviews. National Institute for Health Research. 2023. https:\/\/www.crd.york.ac.uk\/prospero\/.  Accessed 2025 Apr."},{"key":"1356_CR31","unstructured":"US Food and Drug Administration. Medical devices. Nucleic acid based tests. https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/nucleic-acid-based-tests. Accessed Nov 2024."},{"key":"1356_CR32","unstructured":"European Medicines Agency. Human regulatory: overview. Medical devices. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/medical-devices."},{"key":"1356_CR33","unstructured":"Evidence Partners. DistillerSR (Version 2025.3). https:\/\/www.evidencepartners.com\/. Accessed 2025 May."},{"key":"1356_CR34","unstructured":"Joanna Briggs Institute. Critical appraisal tools. https:\/\/jbi.global\/critical-appraisal-tools. Accessed May 2025."},{"issue":"4","key":"1356_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404.","journal-title":"Biometrika"},{"key":"1356_CR36","unstructured":"US Food and Drug Administration. CLIA categorizations. https:\/\/www.fda.gov\/medical-devices\/ivd-regulatory-assistance\/clia-categorizations. Accessed 2025 Nov."},{"issue":"1","key":"1356_CR37","doi-asserted-by":"publisher","first-page":"13496","DOI":"10.1038\/s41598-020-70090-2","volume":"10","author":"I Takayama","year":"2020","unstructured":"Takayama I, Semba S, Yokono K, et al. Clinical evaluation of fully automated molecular diagnostic system \u201cSimprova\u201d for influenza virus, respiratory syncytial virus, and human metapneumovirus. Sci Rep. 2020;10(1):13496.","journal-title":"Sci Rep"},{"issue":"3","key":"1356_CR38","doi-asserted-by":"publisher","first-page":"e01777","DOI":"10.1128\/JCM.01777-17","volume":"56","author":"F Hassan","year":"2018","unstructured":"Hassan F, Hays LM, Bonner A, et al. Multicenter clinical evaluation of the Alere\u00a0i respiratory syncytial virus isothermal nucleic acid amplification assay. J Clin Microbiol. 2018;56(3):e01777-e1817.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1356_CR39","doi-asserted-by":"publisher","first-page":"e00128","DOI":"10.1128\/JCM.00128-20","volume":"58","author":"CN Murphy","year":"2020","unstructured":"Murphy CN, Fowler R, Balada-Llasat JM, et al. Multicenter evaluation of the BioFire FilmArray pneumonia\/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol. 2020;58(7):e00128-e220.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1356_CR40","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1002\/jmv.26860","volume":"93","author":"TC Morris","year":"2021","unstructured":"Morris TC, Bird PW, Horvath-Papp E, Dhillon JK, May S, Tang JW. Xpert Xpress Flu\/RSV: validation and impact evaluation at a large UK hospital trust. J Med Virol. 2021;93(8):5146\u201351.","journal-title":"J Med Virol"},{"issue":"2","key":"1356_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2022.115764","volume":"104","author":"BS Shihabuddin","year":"2022","unstructured":"Shihabuddin BS, Faron ML, Relich RF, et al. Cepheid Xpert Xpress Flu\/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment. Diagn Microbiol Infect Dis. 2022;104(2):115764.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"1356_CR42","doi-asserted-by":"publisher","first-page":"00018","DOI":"10.1183\/23120541.00018-2020","volume":"6","author":"AJ Allen","year":"2020","unstructured":"Allen AJ, Gonzalez-Ciscar A, Lendrem C, et al. Diagnostic and economic evaluation of a point-of-care test for respiratory syncytial virus. ERJ Open Res. 2020;6(3):00018\u20132020.","journal-title":"ERJ Open Res"},{"issue":"8","key":"1356_CR43","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/jmv.25479","volume":"91","author":"J Rahamat-Langendoen","year":"2019","unstructured":"Rahamat-Langendoen J, Groenewoud H, Kuijpers J, Melchers WJG, Wilt GJVD. Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study. J Med Virol. 2019;91(8):1408\u201314.","journal-title":"J Med Virol"},{"issue":"11","key":"1356_CR44","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1099\/jmm.0.000841","volume":"67","author":"YII Ho","year":"2018","unstructured":"Ho YII, Wong AH, Lai RWM. Comparison of the Cepheid Xpert Xpress Flu\/RSV assay to in-house Flu\/RSV triplex real-time RT-PCR for rapid molecular detection of influenza A, influenza B and respiratory syncytial virus in respiratory specimens. J Med Microbiol. 2018;67(11):1576\u201380.","journal-title":"J Med Microbiol"},{"issue":"5","key":"1356_CR45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1086\/650486","volume":"50","author":"HK Talbot","year":"2010","unstructured":"Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis. 2010;50(5):747\u201351.","journal-title":"Clin Infect Dis"},{"issue":"Supplement_7","key":"1356_CR46","doi-asserted-by":"publisher","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","volume":"222","author":"T Shi","year":"2020","unstructured":"Shi T, Denouel A, Tietjen AK, et al. Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis. 2020;222(Supplement_7):S577\u201383.","journal-title":"J Infect Dis"},{"issue":"8","key":"1356_CR47","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/INF.0000000000002626","volume":"39","author":"T Utsunomiya","year":"2020","unstructured":"Utsunomiya T, Hibino A, Taniguchi K, et al. Factors contributing to symptom duration and viral reduction in outpatient children with respiratory syncytial virus infection. Pediatr Infect Dis J. 2020;39(8):678\u201383.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1356_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-3476(76)80918-3","volume":"89","author":"CB Hall","year":"1976","unstructured":"Hall CB, Douglas RG, Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr. 1976;89(1):11\u20135.","journal-title":"J Pediatr"},{"issue":"1","key":"1356_CR49","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1093\/infdis\/jiaf204","volume":"232","author":"E Begier","year":"2025","unstructured":"Begier E, Aliabadi N, Ramirez JA, et al. Detection by nasopharyngeal swabs alone underestimates respiratory syncytial virus-related hospitalization incidence in adults: the Multispecimen Study\u2019s final analysis. J Infect Dis. 2025;232(1):e126\u201336.","journal-title":"J Infect Dis"},{"key":"1356_CR50","unstructured":"Stafford R. ACON laboratories announces breakthrough 4-in-1 Flowflex\u00ae plus RSV + Flu A\/B + COVID home test. https:\/\/flowflexcovid.com\/acon-laboratories-announces-breakthrough-4-in-1-flowflex-plus-rsv-flu-a-b-covid-home-test\/. Accessed 2025 Nov."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01356-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:50:33Z","timestamp":1779972633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01356-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01356-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Ornella Ruiz, Suzie Seabroke, Konstantina Chatzikonstantinidou, and Laura E. Sarabia are employees of P95, which received funding from Pfizer Inc. in connection with this research and the development of this manuscript. Kashmira Date, Kyle Fowler, Mary Lynn Baniecki, Katherine K. Perez, Sima S. Toussi, Elaine Thomas, Katherine T. Schneider, and Elizabeth Begier are employees of Pfizer Inc. Bradford Gessner was affiliated with Pfizer Inc. while conducting this study and joined EpiVac Consulting during manuscript completion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}